Clinical Trial Update: Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

View source ↗

Summary

Clinical trial update reporting the effectiveness and safety of dalteparin in patients with acute coronary syndrome without ST elevations in routine clinical pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Myocardial Infarction
• Unstable Angina

Drugs mentioned

• FRAGMIN (DALTEPARIN SODIUM)

Snippet

Sponsor: Pfizer | Conditions: Acute Coronary Syndrome | Status: COMPLETED | Results posted: 2011-11-11